|
시장보고서
상품코드
1413718
세계의 조직은행 시장 예측(-2030년)Tissue Banking Market Research Report Forecast till 2030 |
||||||
세계 조직은행 시장 규모는 조사 기간 동안 연평균 8.5%의 견조한 성장세를 보일 것으로 예상됩니다.
지역별 인사이트
첨단 기술에 대한 접근성, 의료 체계의 확장, 북미의 조직 은행 발전을 촉진하는 금융 환경 등으로 인해 북미가 2022년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
유럽 시장은 연구개발 운동 증가 등으로 인해 시장 점유율 2위를 차지할 것으로 예상됩니다. 이 지역의 장기 기증자 수 증가도 조직 은행의 발전을 촉진하고 있습니다.
아시아태평양 시장은 조사 기간 동안 6.90%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
이 보고서는 세계 조직은행 시장을 조사 분석하여 시장 역학, 지역 및 부문 분석, 기업 프로파일 등의 정보를 제공합니다.
목차
제1장 주요 요약
- 시장의 매력 분석
- 세계의 조직은행 시장 : 유형별
- 세계의 조직은행 시장 : 조직 유형별
- 세계의 조직은행 시장 : 용도별
- 세계의 조직은행 시장 : 지역별
제2장 시장 서론
제3장 조사 방법
제4장 시장 역학
- 서론
- 성장 촉진요인
- 성장 억제요인
- 기회
제5장 시장 요인 분석
- 밸류체인 분석
- Porter의 Five Forces 분석
- COVID-19의 영향 분석
- 시장에 대한 영향 분석
- 지역에 대한 영향
- 기회와 위협 분석
제6장 세계의 조직은행 시장 : 유형별
- 개요
- 배지 및 소모품
- 냉동 보존 장비
- 해동 장비
- 품질관리 장비
- 기타
제7장 세계의 조직은행 시장 : 조직 유형별
- 개요
- 심장판막
- 각막
- 뼈
- 피부
- 뇌 및 척수
- 기타
제8장 세계의 조직은행 시장 : 용도별
- 개요
- 치료
- 의학 연구
- 기타
제9장 세계의 조직은행 시장 : 지역별
- 개요
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- 기타 아시아태평양
- 기타 지역
- 중동
- 아프리카
- 라틴아메리카
제10장 경쟁 구도
- 서론
- 경쟁 분석
- 시장 점유율 분석
- 세계 조직은행 시장의 주요 성장 전략
- 경쟁 벤치마킹
- 세계의 조직은행 시장 개발 건수 기준 주요 기업
- 주요 발전과 성장 전략
- 신제품 발매
- 인수합병(M&A)
- 합작투자(JV)
- 주요 기업의 재무 매트릭스
- 판매 및 영업이익(2022년)
- 주요 기업 연구개발 지출(2022년)
제11장 기업 개요
- THERMO FISHER SCIENTIFIC INC
- BIOLIFESOLUTIONS
- LIFELINE SCIENTIFIC
- BIOCISION, CESCA THERAPEUTICS, INC
- CORE DYNAMICS GMBH
- CUSTOM BIOGENIC SYSTEMS
- ATLANTA BIOLOGICS PVT. LTD
- TAYLOR-WHARTON
- PANASONIC HOLDINGS CORPORATION
제12장 부록
LSH 24.01.31Market Overview
Tissue Banking Market is anticipated to register a healthy CAGR of 8.5% during the review period.
The rising predominance of constant sicknesses like malignant growth, coronary illness, and diabetes infection significantly influence all around the world as well as raises the interest for cutting edge treatment options for the treatment of persistent sickness. As rising gamble of constant sickness appears to be the best treatment elective for tissue banking. What's more, according to the American Malignant growth Society, around 1.9 million new instances of disease were analysed in the US. Moreover, coronary illness is considered as the main source of death for ladies and men. One individual kick the bucket like clockwork in the US from cardiovascular illness. Around 4,66,566 individuals experienced coronary illness in the US. Coronary illness costs the US around USD 239.9 billion consistently from 2018 to 2019. Hence, the rising commonness of coronary illness disease, and diabetes is expanding the interest in tissue banking so central participants are distinctly interested in the research and improvement movement for new item advancement which pushes the development of tissue banking.
Market Segmentation
The Tissue Banking Market segmentation, based on type, includes media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, and others.
The Tissue Banking Market segmentation is based on tissue types that include heart valve, cornea, bone, skin, brain & spinal cord, and others.
The Tissue Banking Market segmentation is based on applications that include therapeutics, medical research, and others.
Regional Insights
North America represented the biggest market share in 2022 attributable to the North America is supposed to order the biggest market share because of the rising propensity of egg frozen in the US, accessibility of advance innovation, expanding medical care framework, created monetary condition boos the development of tissue banking in the North America region.
Europe tissue banking market is supposed to represent the second-biggest market share because of the development of the market are expanding mechanical turn of events and item advancement, rising research and improvement movement, expanding event of life threating sickness like coronary illness, malignant growth, and others. Moreover, expanding quantities of organ contributors across the region is driving the development of tissue banking.
The Asia-Pacific tissue banking market is anticipated to register a CAGR of 6.90% during the review period. This is because of expanding venture by unfamiliar organizations, colossal ongoing sickness populace, expanding entrance of frozen eggs are driving the development of tissue banking in the Asia-pacific region.
Latin America holds the significant market share in the middle east and Africa region because of the region's development is credited to a developing utilization of tissue banking, rising mindfulness about the organ gift for saving other life, developing new mechanical turn of events and advance clinical office across the region are help the development of tissue banking in region.
Major Players
The key market players are Applied Biosystems, Custom Biogenic Systems (US), Invitrogen, Thermo Scientific, Fisher Scientific, Cesca Therapeutics, Inc. (US), Unity Lab Services, BioLife Solutions (US), Atlanta Biologics Pvt. Ltd. (US), Lifeline Scientific (US), BioCision, core dynamics GmbH (US), Taylor-Wharton (US), and Panasonic Holdings Corporation (Japan).
TABLE OF CONTENTS
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
- 1.1. MARKET ATTRACTIVENESS ANALYSIS
- 1.1.1. GLOBAL TISSUE BANKING MARKET, BY TYPE
- 1.1.2. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE
- 1.1.3. GLOBAL TISSUE BANKING MARKET, BY APPLICATION
- 1.1.4. GLOBAL TISSUE BANKING MARKET, BY REGION
2. MARKET INTRODUCTION
- 2.1. DEFINITION
- 2.2. SCOPE OF THE STUDY
- 2.3. MARKET STRUCTURE
3. RESEARCH METHODOLOGY
- 3.1. OVERVIEW
- 3.2. DATA MINING
- 3.3. SECONDARY RESEARCH
- 3.4. PRIMARY RESEARCH
- 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
- 3.5. FORECASTING TECHNIQUE
- 3.6. MARKET SIZE ESTIMATION
- 3.6.1. BOTTOM-UP APPROACH
- 3.6.2. TOP-DOWN APPROACH
- 3.7. DATA TRIANGULATION
- 3.8. VALIDATION
4. MARKET DYNAMICS
- 4.1. INTRODUCTION
- 4.2. DRIVERS
- 4.3. RESTRAINTS
- 4.4. OPPORTUNITIES
5. MARKET FACTOR ANALYSIS
- 5.1. VALUE CHAIN ANALYSIS
- 5.2. PORTER'S FIVE FORCES ANALYSIS
- 5.2.1. BARGAINING POWER OF SUPPLIERS
- 5.2.2. BARGAINING POWER OF BUYERS
- 5.2.3. THREAT OF NEW ENTRANTS
- 5.2.4. THREAT OF SUBSTITUTES
- 5.2.5. INTENSITY OF RIVALRY
- 5.3. COVID-19 IMPACT ANALYSIS
- 5.3.1. MARKET IMPACT ANALYSIS
- 5.3.2. REGIONAL IMPACT
- 5.3.3. OPPORTUNITY AND THREAT ANALYSIS
6. GLOBAL TISSUE BANKING MARKET, BY TYPE
- 6.1. OVERVIEW
- 6.2. MEDIA AND CONSUMABLE
- 6.3. CRYOPRESERVATION EQUIPMENT
- 6.4. THAWING EQUIPMENT
- 6.5. QUALITY CONTROL EQUIPMENT
- 6.6. OTHERS
7. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE
- 7.1. OVERVIEW
- 7.2. HEART VALVE
- 7.3. CORNEA
- 7.4. BONE
- 7.5. SKIN
- 7.6. BRAIN & SPINAL CORD
- 7.7. OTHERS
8. GLOBAL TISSUE BANKING MARKET, BY APPLICATION
- 8.1. OVERVIEW
- 8.2. THERAPEUTICS
- 8.3. MEDICAL RESEARCH
- 8.4. OTHERS
9. GLOBAL TISSUE BANKING MARKET, BY REGION
- 9.1. OVERVIEW
- 9.2. NORTH AMERICA
- 9.2.1. US
- 9.2.2. CANADA
- 9.3. EUROPE
- 9.3.1. GERMANY
- 9.3.2. FRANCE
- 9.3.3. UK
- 9.3.4. ITALY
- 9.3.5. SPAIN
- 9.3.6. REST OF EUROPE
- 9.4. ASIA-PACIFIC
- 9.4.1. CHINA
- 9.4.2. INDIA
- 9.4.3. JAPAN
- 9.4.4. AUSTRALIA
- 9.4.5. SOUTH KOREA
- 9.4.6. REST OF ASIA-PACIFIC
- 9.5. REST OF THE WORLD
- 9.5.1. MIDDLE EAST
- 9.5.2. AFRICA
- 9.5.3. LATIN AMERICA
10. COMPETITIVE LANDSCAPE
- 10.1. INTRODUCTION
- 10.2. COMPETITIVE ANALYSIS
- 10.3. MARKET SHARE ANALYSIS
- 10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL TISSUE BANKING MARKET
- 10.5. COMPETITIVE BENCHMARKING
- 10.6. LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL TISSUE BANKING MARKET
- 10.7. KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.7.1. NEW PRODUCT LAUNCH
- 10.7.2. MERGER & ACQUISITION
- 10.7.3. JOINT VENTURES
- 10.8. MAJOR PLAYERS FINANCIAL MATRIX
- 10.8.1. SALES & OPERATING INCOME, 2022
- 10.8.2. MAJOR PLAYERS R&D EXPENDITURE, 2022
11. COMPANY PROFILES
- 11.1. THERMO FISHER SCIENTIFIC INC
- 11.1.1. COMPANY OVERVIEW
- 11.1.2. FINANCIAL OVERVIEW
- 11.1.3. TYPES OFFERED
- 11.1.4. KEY DEVELOPMENTS
- 11.1.5. SWOT ANALYSIS
- 11.1.6. KEY STRATEGIES
- 11.2. BIOLIFESOLUTIONS
- 11.3. LIFELINE SCIENTIFIC
- 11.4. BIOCISION, CESCA THERAPEUTICS, INC
- 11.5. CORE DYNAMICS GMBH
- 11.6. CUSTOM BIOGENIC SYSTEMS
- 11.7. ATLANTA BIOLOGICS PVT. LTD
- 11.8. TAYLOR-WHARTON
- 11.9. PANASONIC HOLDINGS CORPORATION
12. APPENDIX
- 12.1. REFERENCE REPORT
- 12.2. RELATED REPORTS
